Irinotecan + floxuridine + folinic acid may extend survival in colorectal cancer Clinical study 02 February 2013 Pages: 19 - 19
Rifampicin, colestyramine or opioid antagonists for cholestasis-associated pruritus Review 02 February 2013 Pages: 19 - 19
Genetic polymorphism predicts citalopram adverse-effect burden Clinical study 02 February 2013 Pages: 20 - 20
US FDA approves use of genetic testing to estimate warfarin dose News item 02 February 2013 Pages: 20 - 20
Increased iron mobilisation behind gadodiamide-associated NSF? Clinical study 02 February 2013 Pages: 21 - 21
EMEA approves convenience enhancements for nonacog alfa Media release 02 February 2013 Pages: 22 - 22
Sodium phenylbutyrate granted orphan drug status in the US Media release 02 February 2013 Pages: 23 - 23